SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Clinical and Applied Thrombosis/Hemostasis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1076029607310218v1
15/3/356    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sottilotta, G.
Right arrow Articles by Trapani Lombardo, V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sottilotta, G.
Right arrow Articles by Trapani Lombardo, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

High Incidence of Factor V Leiden and Prothrombin G20210A in Healthy Southern Italians

Gianluca Sottilotta, MD

Centro Emofilia, Servizio Emostasi e Trombosi Azienda Ospedaliera "Bianchi-Melacrino-Morelli," Reggio Calabria, Italy, sottilotta{at}centroemofilia.it

Corrado Mammì, MD,

Unità Operativa di Genetica Medica Azienda Ospedaliera "Bianchi-Melacrino-Morelli," Reggio Calabria, Italy

Giuseppe Furlò, MD

Servizio di Immunoematologia e Medicina Trasfusionale, Azienda Ospedaliera "Bianchi-Melacrino-Morelli," Reggio Calabria, Italy

Vincenzo Oriana, MD

Centro Emofilia, Servizio Emostasi e Trombosi Azienda Ospedaliera "Bianchi-Melacrino-Morelli," Reggio Calabria, Italy

Caterina Latella, MD

Centro Emofilia, Servizio Emostasi e Trombosi Azienda Ospedaliera "Bianchi-Melacrino-Morelli," Reggio Calabria, Italy

Vincenzo Trapani Lombardo, MD

Centro Emofilia, Servizio Emostasi e Trombosi Azienda Ospedaliera "Bianchi-Melacrino-Morelli," Reggio Calabria, Italy

Factor V Leiden (FVL) and G20210 prothrombin (FII G20210A) mutations are risk factors for thromboembolism. In Europe, FVL is more prevalent in the north (7%) than in the south (3%), whereas FII G20210A is more common in the south (3% to 7%) than in the north (2% to 5%). In Italy, the prevalence is 2% to 3% for both. The aim of this study was to assess if these polymorphisms could be more frequent in the south than in the rest of Italy. In 105 blood donors in southern Italy, the prevalence of FVL and FIIG20210A was 9.5% and 5.7%, respectively. These prevalence data are higher when compared with published data. The results of this study are as high as those observed in Greece and the Middle East. The diffusion of FVL and FII G20210A in the Mediterranean, consequent to Phoenician and Greek colonization, could be a reason for the high prevalence observed.

Key Words: thrombophilia • factor V Leiden • prothrombin G20210

This version was published on June 1, 2009

Clinical and Applied Thrombosis/Hemostasis, Vol. 15, No. 3, 356-359 (2009)
DOI: 10.1177/1076029607310218


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement